• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的抗抑郁治疗。去甲替林对接受左旋多巴治疗的帕金森病患者疗效的对照试验。

Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA.

作者信息

Andersen J, Aabro E, Gulmann N, Hjelmsted A, Pedersen H E

出版信息

Acta Neurol Scand. 1980 Oct;62(4):210-9. doi: 10.1111/j.1600-0404.1980.tb03028.x.

DOI:10.1111/j.1600-0404.1980.tb03028.x
PMID:7010875
Abstract

Nineteen patients with L-DOPA treated parkinsonism involving depressive symptoms, the therapeutic effect of nortriptyline was compared to placebo in a controlled trial. The depressive and neurological symptoms were evaluated by rating scales. Nortriptyline had a clinical significant effect with regard to the depressive symptoms, whereas the neurological parameters were unchanged. The authors suggest the depression in Parkinson's disease to be of both reactive and endogenous origins.

摘要

19例接受左旋多巴治疗且伴有抑郁症状的帕金森病患者,在一项对照试验中比较了去甲替林与安慰剂的治疗效果。通过评定量表评估抑郁和神经症状。去甲替林对抑郁症状有显著临床疗效,而神经参数未改变。作者认为帕金森病中的抑郁既有反应性起源也有内源性起源。

相似文献

1
Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA.帕金森病的抗抑郁治疗。去甲替林对接受左旋多巴治疗的帕金森病患者疗效的对照试验。
Acta Neurol Scand. 1980 Oct;62(4):210-9. doi: 10.1111/j.1600-0404.1980.tb03028.x.
2
Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease.抗抑郁药治疗帕金森病试验(ADepT-PD):一项关于依他普仑和去甲替林治疗帕金森病患者抑郁症状的有效性的随机安慰剂对照试验方案。
BMC Neurol. 2022 Dec 12;22(1):474. doi: 10.1186/s12883-022-02988-5.
3
Depression treatment in Parkinson's disease.
DICP. 1991 Feb;25(2):137-8.
4
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.依托必利可对抗帕金森病中左旋多巴诱导的运动障碍:一项剂量探索研究。
Brain. 2015 Apr;138(Pt 4):963-73. doi: 10.1093/brain/awu409. Epub 2015 Feb 10.
5
AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.AFQ056 在伴有左旋多巴诱导运动障碍的帕金森病患者中的 13 周、随机、剂量发现研究。
Mov Disord. 2013 Nov;28(13):1838-46. doi: 10.1002/mds.25561. Epub 2013 Jul 12.
6
Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management.帕金森病中的抑郁:急性药物治疗管理后的症状改善和残留症状。
Am J Geriatr Psychiatry. 2011 Mar;19(3):222-9. doi: 10.1097/JGP.0b013e3181e448f7.
7
The L-dopa sparing effect of G 31,406 in the treatment of parkinson's disease.G 31,406在帕金森病治疗中的左旋多巴节省效应。
Neurol Neurocir Psiquiatr. 1976;17(4):285-92.
8
Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.帕金森病患者中,玛伐谷氨酸(AFQ056)与增加左旋多巴剂量联合使用。
Int J Neurosci. 2016;126(1):20-4. doi: 10.3109/00207454.2013.841685. Epub 2015 Aug 18.
9
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.普拉克索治疗帕金森病患者抑郁症状的随机、双盲、安慰剂对照试验。
Lancet Neurol. 2010 Jun;9(6):573-80. doi: 10.1016/S1474-4422(10)70106-X. Epub 2010 May 7.
10
The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease.抗抑郁治疗对帕金森病伴抑郁患者认知功能的影响。
J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):188-95. doi: 10.1176/jnp.2010.22.2.188.

引用本文的文献

1
Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis.抗抑郁药对患有躯体疾病和抑郁症个体的疗效及耐受性:网状Meta分析
Br J Psychiatry. 2025 Apr 4:1-14. doi: 10.1192/bjp.2025.18.
2
German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson's disease: new spotlights on diagnostic procedures and non-pharmacological interventions.德国神经病学会关于帕金森病患者认知障碍和情感障碍的诊断和治疗指南:诊断程序和非药物干预的新重点。
J Neurol. 2024 Nov;271(11):7330-7357. doi: 10.1007/s00415-024-12503-0. Epub 2024 Aug 9.
3
Depression and Parkinson's disease: a Chicken-Egg story.
抑郁症与帕金森病:先有鸡还是先有蛋的问题。
AIMS Neurosci. 2022 Nov 23;9(4):479-490. doi: 10.3934/Neuroscience.2022027. eCollection 2022.
4
The pharmacologic management of depression in Parkinson's disease.帕金森病抑郁的药物治疗
Degener Neurol Neuromuscul Dis. 2013 Jan 17;3:1-9. doi: 10.2147/DNND.S36917. eCollection 2013.
5
The Pathophysiology of Fatigue in Parkinson's Disease and its Pragmatic Management.帕金森病疲劳的病理生理学及其实用管理
Mov Disord Clin Pract. 2016 Mar 11;3(4):323-330. doi: 10.1002/mdc3.12343. eCollection 2016 Jul-Aug.
6
Antidepressants for Depression, Apathy, and Gait Instability in Parkinson's Disease: A Multicenter Randomized Study.抗抑郁药治疗帕金森病的抑郁、冷漠和步态不稳:一项多中心随机研究
Intern Med. 2019 Feb 1;58(3):361-368. doi: 10.2169/internalmedicine.1359-18. Epub 2018 Aug 24.
7
Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.抗抑郁药治疗帕金森病的疗效和耐受性:系统评价和网络荟萃分析。
Int J Geriatr Psychiatry. 2018 Apr;33(4):642-651. doi: 10.1002/gps.4834. Epub 2017 Dec 13.
8
Monoamine reuptake inhibitors in Parkinson's disease.单胺再摄取抑制剂在帕金森病中的应用。
Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25.
9
A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease.帕金森病中抑郁和焦虑的随机安慰剂对照治疗试验的荟萃分析。
PLoS One. 2013 Nov 13;8(11):e79510. doi: 10.1371/journal.pone.0079510. eCollection 2013.
10
Depression and Parkinson's disease: current knowledge.抑郁与帕金森病:当前的认识。
Curr Neurol Neurosci Rep. 2013 Dec;13(12):409. doi: 10.1007/s11910-013-0409-5.